Stay updated with breaking news from Akoya biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Akoya Biosciences (NASDAQ:AKYA) and Revvity (NYSE:RVTY) Financial Analysis theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Akoya Biosciences (NASDAQ:AKYA – Get Free Report) had its price target decreased by equities research analysts at Morgan Stanley from $16.00 to $15.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s target price points to a potential upside of 141.16% […] ....
MARLBOROUGH, Mass., Aug. 07, 2023 Akoya Biosciences , Inc. , The Spatial Biology Company®, today announced a momentous achievement - publication of the 1,000th peer-reviewed article citing. ....
During the forecast period. The AI in pathology market refers to the sector within the healthcare industry that encompasses the development, deployment,. ....
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.